{"id":1300,"date":"1994-06-30T00:00:00","date_gmt":"1994-06-29T22:00:00","guid":{"rendered":"https:\/\/preprod.retinegallien.com\/publication\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\/"},"modified":"1994-06-30T00:00:00","modified_gmt":"1994-06-29T22:00:00","slug":"technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag","status":"publish","type":"publication","link":"https:\/\/www.retinegallien.com\/en\/publication\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\/","title":{"rendered":"Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG."},"content":{"rendered":"<p>Chauvel P,Brassart N,Herault J,Courdi A,CaujolleJP,Grange JD, Mouries O,<strong> Diallo-Rosier L<\/strong>, Mosci C, Polizzi A, Porta A, Menci E, Bornfeld N, Friedrichs W, Sahel J, Bacin F, Ge \u0301rard JP, Sauerwein W, Scolaro T, Carrie C, Kantor G, Rozan R, Teissier T, Bensadoun RJ, Lagrange JL, Demard F. Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG. In: <strong>Frezzotti R, Balestrazzi E, Falco L, Esente S, editors. International Symposium on Intraocular and Epibulbar Tumors. Bologna: Monduzzi Editore; 1994. p. 99\u2013 103.<\/strong><br \/><\/br \/><\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"class_list":["post-1300","publication","type-publication","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG. - R\u00e9tine Gallien<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.retinegallien.com\/en\/publication\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG. - R\u00e9tine Gallien\" \/>\n<meta property=\"og:description\" content=\"Chauvel P,Brassart N,Herault J,Courdi A,CaujolleJP,Grange JD, Mouries O, Diallo-Rosier L, Mosci C, Polizzi A, Porta A, Menci E, Bornfeld N, Friedrichs W, Sahel J, Bacin F, Ge \u0301rard JP, Sauerwein W, Scolaro T, Carrie C, Kantor G, Rozan R, Teissier T, Bensadoun RJ, Lagrange JL, Demard F. Technical considerations about protontherapy and visual conservation for [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.retinegallien.com\/en\/publication\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\/\" \/>\n<meta property=\"og:site_name\" content=\"R\u00e9tine Gallien\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\\\/\",\"url\":\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\\\/\",\"name\":\"Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG. - R\u00e9tine Gallien\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#website\"},\"datePublished\":\"1994-06-29T22:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\",\"item\":\"https:\\\/\\\/www.retinegallien.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#website\",\"url\":\"https:\\\/\\\/www.retinegallien.com\\\/\",\"name\":\"R\u00e9tine Gallien\",\"description\":\"Cabinet Ophtalmologie \u00e0 Bordeaux\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.retinegallien.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#organization\",\"name\":\"R\u00e9tine Gallien\",\"url\":\"https:\\\/\\\/www.retinegallien.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.retinegallien.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.retinegallien.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/logo.png\",\"width\":322,\"height\":161,\"caption\":\"R\u00e9tine Gallien\"},\"image\":{\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG. - R\u00e9tine Gallien","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.retinegallien.com\/en\/publication\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\/","og_locale":"en_US","og_type":"article","og_title":"Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG. - R\u00e9tine Gallien","og_description":"Chauvel P,Brassart N,Herault J,Courdi A,CaujolleJP,Grange JD, Mouries O, Diallo-Rosier L, Mosci C, Polizzi A, Porta A, Menci E, Bornfeld N, Friedrichs W, Sahel J, Bacin F, Ge \u0301rard JP, Sauerwein W, Scolaro T, Carrie C, Kantor G, Rozan R, Teissier T, Bensadoun RJ, Lagrange JL, Demard F. Technical considerations about protontherapy and visual conservation for [&hellip;]","og_url":"https:\/\/www.retinegallien.com\/en\/publication\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\/","og_site_name":"R\u00e9tine Gallien","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.retinegallien.com\/en\/publication\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\/","url":"https:\/\/www.retinegallien.com\/en\/publication\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\/","name":"Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG. - R\u00e9tine Gallien","isPartOf":{"@id":"https:\/\/www.retinegallien.com\/#website"},"datePublished":"1994-06-29T22:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.retinegallien.com\/en\/publication\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.retinegallien.com\/en\/publication\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.retinegallien.com\/en\/publication\/technical-considerations-about-protontherapy-and-visual-conservation-for-uveal-melanomas-the-experience-of-the-serag\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"","item":"https:\/\/www.retinegallien.com\/"},{"@type":"ListItem","position":2,"name":"Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG."}]},{"@type":"WebSite","@id":"https:\/\/www.retinegallien.com\/#website","url":"https:\/\/www.retinegallien.com\/","name":"R\u00e9tine Gallien","description":"Cabinet Ophtalmologie \u00e0 Bordeaux","publisher":{"@id":"https:\/\/www.retinegallien.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.retinegallien.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.retinegallien.com\/#organization","name":"R\u00e9tine Gallien","url":"https:\/\/www.retinegallien.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.retinegallien.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.retinegallien.com\/wp-content\/uploads\/2024\/12\/logo.png","contentUrl":"https:\/\/www.retinegallien.com\/wp-content\/uploads\/2024\/12\/logo.png","width":322,"height":161,"caption":"R\u00e9tine Gallien"},"image":{"@id":"https:\/\/www.retinegallien.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.retinegallien.com\/en\/wp-json\/wp\/v2\/publication\/1300","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.retinegallien.com\/en\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/www.retinegallien.com\/en\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/www.retinegallien.com\/en\/wp-json\/wp\/v2\/media?parent=1300"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}